Bill > H3119

This bill proposes to add a new section to South Carolina law requiring comprehensive testing and labeling of blood, tissue, and organ donations for "high-count spike proteins from long COVID-19 or products created from gene therapy biologics". Healthcare providers would be mandated to send all donated products to a licensed laboratory for testing before distribution, and clearly label any products found to contain these specified contaminants. Patients must provide written consent before receiving donations containing these markers and can decline such products without facing any penalties or negative consequences. Healthcare providers who violate these requirements would be subject to a $500 fine per patient, while providers following the law would receive immunity from prosecution or civil penalties related to potential damages from these contaminants. The bill defines "gene therapy biologics" as biological products capable of altering or interfering with genes, specifically including messenger RNA. The legislation would take effect immediately upon the Governor's approval, aiming to provide transparency and patient choice in medical donations and procedures involving blood, tissue, and organ transfers.

Health and Social Services

https://www.scstatehouse.gov/billsearch.php?billnumbers=3119&session=126&summary=B